Kineret CAPS Post Authorisation Study
Non-interventional PASS to Evaluate Safety of Kineret in Treatment of CAPS in Routine Clinical Care With Regard to Serious Infections, Malignancies, Injection Site Reactions, Allergic Reactions, Medication Errors Including Re-use of Syringe
Sponsor: Pediatric Rheumatology International Trials Organization
Listed as NCT02326376, this observational or N/A phase trial focuses on Cryopyrin-Associated Periodic Syndromes and remains completed. Sponsored by Pediatric Rheumatology International Trials Organization, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting
▶ Show 5 earlier versions
-
Oct 2018 — Nov 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pediatric Rheumatology International Trials Organization
- Swedish Orphan Biovitrum
For direct contact, visit the study record on ClinicalTrials.gov .